Have a personal or library account? Click to login
Selected tumour biomarker levels in sheep with pulmonary adenomatosis Cover

Selected tumour biomarker levels in sheep with pulmonary adenomatosis

Open Access
|Mar 2020

References

  1. Amini F., Mostafa-Tehrani A.: A five-year survey (2002–2007) on ovine pulmonary adenomatosis in a mixed-breed sheep flock. Bulg J Vet Med 2013, 16, 139–142.
  2. Azizi S., Tajbakhsh E., Fathi F.: Ovine pulmonary adenocarcinoma in slaughtered sheep: A pathological and polymerase chain reaction study. J S Afr Vet Assoc 2014, 85, 1–5.
  3. Bashizadeh-Fakhar H., Rezaie-Tavirani M., Zali H., Faraji R., Nejad E.K., Aghazadeh M.: The diagnostic value of serum CEA, CA-125, and ROMA Index in low-grade serous ovarian cancer. Int J Cancer 2018, 11, e63397.
  4. Beytut E., Sözmen M., Erginsoy S.: Immunohistochemical detection of pulmonary surfactant proteins and retroviral antigens in the lungs of sheep with pulmonary adenomatosis. J Comp Pathol 2009, 140, 43–53.
  5. Can-Sahna K., Eroksuz Y., Berber E., Sozdutmaz I.: Detection of exogenous Jaagsiekte sheep retrovirus in Turkey. Indian J Anim Sci 2015, 49, 498–502.
  6. Chen F., Li J., Qi X., Qi J.: Diagnostic value of CYFRA 21-1 and carcinoembryonic antigen in diagnosis of operable lung cancer from benign lung disease. J Cancer Res Ther 2018, 14, 400–404.
  7. Chen F., Shen J., Wang J., Cai P., Huang Y.: Clinical analysis of four serum tumor markers in 458 patients with ovarian tumors: diagnostic value of the combined use of HE4, CA125, CA19-9, and CEA in ovarian tumors. Cancer Manag Res 2018, 10, 1313–1318.
  8. Crosbie P.A.J., Shah R., Summers Y., Dive C., Blackhall F.: Prognostic and predictive biomarkers in early stage NSCLC: CTCs and serum/plasma markers. Transl Lung Cancer Res 2013, 2, 382–397.
  9. Dudek K., Lutnicki K., Bednarek D., Marczuk J., Kycko A., Reichert M.: Changes in blood parameters induced by experimental jaagsiekte sheep retrovirus infection. J Vet Res 2016, 60, 245–251.
  10. Duffy M.J.: Tumor markers in clinical practice: a review focusing on common solid cancers. Med Prin Pract 2013, 22, 4–11.
  11. Gonzalez L., Garcia-Goti M., Cousens C., Dewar P., Cortabarria N., Extramiana A.B., Ortin A., De las Heras M., Sharp J.M.: Jaagsiekte sheep retrovirus can be detected in the peripheral blood during the pre-clinical period of sheep pulmonary adenomatosis. J Gen Virol 2001, 82, 1355–1358.
  12. Griffiths D.J., Martineau H.M., Cousens C.: Pathology and pathogenesis of ovine pulmonary adenocarcinoma. J Comp Pathol 2010, 142, 260–283.
  13. Hod I., Herz A., Zimber A.: Pulmonary carcinoma (Jaagsiekte) of sheep. Ultrastructural study of early and advanced tumor lesions. Am J Pathol 1977, 86, 545–558.
  14. Ilhan F., Vural S.A., Yildirim S., Sözdutmaz I., Alcigir M.E.: Expression of p53 protein, Jaagsiekte sheep retrovirus matrix protein, and surfactant protein in the lungs of sheep with pulmonary adenomatosis. J Vet Diagn Invest 2016, 28, 249–256.
  15. Isaksson S., Jönsson P., Monsef N., Brunnstrom H., Bendahl P.O., Jonsson M., Staaf J., Planck M.: CA 19-9 and CA 125 as potential predictors of disease recurrence in resectable lung adenocarcinoma. PLoS One 2017, 12, e0186284.
  16. Jiang Z.F., Wang M., Xuc J.L.: Thymidine kinase 1 combined with CEA, CYFRA21-1 and NSE improved its diagnostic value for lung cancer. Life Sci 2018, 194, 1–6.
  17. Kıran M.M.: Pathological investigations on sheep pulmonary adenomatosis. Selcuk Univ J Vet Fac 1993, 9, 41–45.
  18. Kıran M.M., Çiftçi M.K., Erer H., Ortatatlı M., Hatipoğlu F., Tuzcu M.: The diagnosis of sheep pulmonary adenomatosis by exfoliative cytology and bronchoalveolar lavage techniques and the comparison of results with histopathologic findings. Ataturk Univ J Vet Sci 2000, 16, 59–68.
  19. Kycko A., Reichert M.: Overexpression of aldolase A and cytokeratin 19 in ovine pulmonary adenocarcinoma. Pol J Vet Sci 2012, 15, 703–709.
  20. Leroux C., Girard N., Cottin V., Greenland T., Mornex J.F., Archer F.: Jaagsiekte sheep retrovirus (JSRV): from virus to lung cancer in sheep. Vet Res 2007, 38, 211–228.
  21. Li X., Asmitananda T., Gao L., Gai D., Song Z., Zhang Y., Ren H., Yang T., Chen T., Chen M: Biomarkers in the lung cancer diagnosis: a clinical perspective. Neoplasma 2012, 59, 500–507.
  22. Liu Y., Zhang Y.F., Sun X.L., Liu S.Y.: Detection of Jaagsiekte sheep retrovirus in the peripheral blood during the pre-clinical period of ovine pulmonary adenomatosis. Gen Mol Res 2016, 15, 8521 doi: 10.4238/gmr.15038521
  23. Ma S., Shen L., Qian N., Chen K.: The prognostic values of CA125, CA19.9, NSE, and SCC for stage I NSCLC are limited. Cancer Biomark 2011, 10, 155–162.
  24. Muleya T., Rolny V., He Y., Wehnl B., Escherich A., Warth A., Stolp C., Schneider M.A., Dienemann H., Meister M., Herth F.J., Dayyani F.: The combination of the blood based tumor biomarkers cytokeratin 19 fragments (CYFRA 21-1) and carcinoembryonic antigen (CEA) as a potential predictor of benefit from adjuvant chemotherapy in early stage squamous cell carcinoma of the lung (SCC). Lung Cancer 2018, 120, 46–53.
  25. Nguyen A.H., Miller E.J., Wichman C.S., Berim I.G., Agrawal D.K.: Diagnostic value of tumor antigens in malignant pleural effusion: a meta-analysis. Transl Res 2015, 166, 433–439.
  26. Nikolouzakis T.K., Vassilopoulou L., Fragkiadaki P., Sapsakos T.M., Papadakis G.Z., Spandidos D.A.: Improving diagnosis, prognosis, and prediction by using biomarkers in CRC patients (Review). Oncol Rep 2018, 39, 2455–2472.
  27. Nisbet D.I., Mackay J.M., Smith W., Gray E.W.: Ultrastructure of sheep pulmonary adenomatosis (Jaagsiekte). J Pathol 1971, 103,157–162.
  28. Palmarini M., Cousens C., Dalziel R.G., Bai J., Stedman K., DeMartini J.C., Sharp J.M.: The exogenous form of jaagsiekte retrovirus is specifically associated with a contagious lung cancer of sheep. J Virol 1996, 70, 1618–1623.
  29. Radad K., Khalil S.: Natural ovine pulmonary adenocarcinoma in an Egyptian sheep farm. Eurasian J Vet Sci 2014, 30, 39–43.
  30. Salgia R., Harpole D., Herndon J.A., Pisick E., Elias A., Skarin A.T.: Role of serum tumor markers CA 125 and CEA in non-small cell lung cancer. Anticancer Res 2001, 21, 1241–1246.
  31. Scott P.R.: Sheep medicine. CRC press, Boca Raton, 2015.
  32. Sonawane G.G., Tripathi B.N., Kumar R., Kumar J.: Diagnosis and prevalence of ovine pulmonary adenocarcinoma in lung tissues of naturally infected farm sheep. Vet World 2016, 9, 365–370, doi:10.14202/vetworld.2016.365-370.
  33. Sozmen M., Beytut E.: An investigation of growth factors and lactoferrin in naturally occurring ovine pulmonary adenomatosis. J Comp Pathol 2012, 147, 441–451.
  34. Tang H., Bai Y., Shen W., Wei Y., Xu M., Zhou X.: Clinical significance of combined detection of interleukin-6 and tumour markers in lung cancer. Autoimmunity 2018 51, 191–198.
  35. Tomita M., Matsuzaki Y., Edagawa M., Shimizu T., Hara M., Onitsuka T.: Prognostic significance of preoperative serum carcinoembryonic antigen level in lung adenocarcinoma but not squamous cell carcinoma. Ann Thorac Cardiovasc Surg 2004, 10, 76–80.
  36. Tsoukalas N., Kostakis I.D., Giaginis C., Tolia M., Galanopoulos M., Kiakou M., Aravantinou-Fatorou E., Tsapakidis K., Baxevanos P., Litos I., Tzouda V., Tzovaras A., Kyrgias G., Tsiambas E., Theocharis S.: carcinoembryonic antigen and carbohydrate antigen 19-9 serum levels in non-small cell lung cancer. J Buon 2017, 22, 1390–1394.
  37. Tuxen M.K., Soletormos G., Dombernowsky P.: Tumor markers in the management of patients with ovarian cancer. Cancer Treat Rev 1995, 21, 215–243.
  38. Wang W.J., Tao Z., Gu W., Sun L.H.: Clinical observations on the association between diagnosis of lung cancer and serum tumor markers in combination. Asian Pac J Cancer Prev 2013, 14, 4369–4371.
  39. Xu-Welliver M., Carbone D.P.: Blood-based biomarkers in lung cancer: prognosis and treatment decisions. Transl Lung Cancer Res 2017, 6, 708–712.
  40. Youssef G., Wallace W.A.H., Dagleish M.P., Cousens C., Griffiths D.J.: Ovine pulmonary adenocarcinoma: a large animal model for human lung cancer. ILAR J 2015, 56, 99–115.
  41. Yu M., Wang Y., Abdalla A.M.E., Liu W., Mei F., Wang J., Ouyang C., Li Y.: Carbohydrate antigens as potential biomarkers for the malignancy in patients with idiopathic deep venous thrombosis: a retrospective cohort study. J Huazhong Univ Sci Technolog 2014, 34, 722–728.
  42. Zamay T.N., Zamay G.S., Kolovskaya O.S., Zukov R.A., Petrova M.M., Gargaun A., Berezovski M.V., Kichkailo A.S.: Current and prospective protein biomarkers of lung cancer. Cancers 2017, 9, 1–22.
Language: English
Page range: 39 - 44
Submitted on: Jul 7, 2019
|
Accepted on: Feb 21, 2020
|
Published on: Mar 8, 2020
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2020 Cumali Özkan, Serkan Yıldırım, Zübeyir Huyut, Mustafa Özbek, published by National Veterinary Research Institute in Pulawy
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.